Related Experiment Video
Updated: Jun 1, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
The search for a chemoprevention agent effective against melanoma: considerations and challenges
1Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. michael.ming@uphs.upenn.edu
Abstract:
Studies examining the potential chemopreventive properties of nonsteroidal anti-inflammatory drugs (NSAIDs) against melanoma report widely varying results. The construction and interpretation of these studies are hampered by many factors, including limited knowledge of the pathogenesis of melanoma, leading to difficulties in determining the relevant factors in the administration of chemopreventive agents and difficulties in assessing long-term use of nonprescription medications. The study by Curiel-Lewandrowski et al. reported in this issue is an important contribution to the literature, but the final verdict regarding the chemopreventive properties of NSAIDs against melanoma is yet to come.
Insights
Nonsteroidal anti-inflammatory drugs (NSAIDs) show varied results for melanoma chemoprevention. Further research is needed to determine their effectiveness and optimal use in preventing melanoma.
Area of Science:
- Oncology
- Pharmacology
- Dermatology
Background:
- Melanoma pathogenesis remains incompletely understood, complicating chemoprevention strategies.
- Assessing long-term use of nonprescription medications like NSAIDs presents challenges.
- Previous studies on NSAIDs for melanoma chemoprevention yield inconsistent findings.
Discussion:
- The study by Curiel-Lewandrowski et al. contributes valuable data to the ongoing investigation.
- Interpreting chemoprevention studies is difficult due to limited knowledge of melanoma development.
- Challenges exist in identifying optimal administration factors for chemopreventive agents.
Key Insights:
- NSAIDs exhibit variable efficacy in preventing melanoma.
- Understanding melanoma's underlying mechanisms is crucial for effective chemoprevention.
- Long-term safety and efficacy data for NSAIDs in melanoma prevention are still developing.
Outlook:
- The definitive role of NSAIDs in melanoma chemoprevention requires further elucidation.
- Continued research is essential to resolve conflicting results and establish guidelines.
- Future studies should focus on refining patient selection and treatment protocols.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

